BIOMAT Database Logo BIOMAT Database Logo

Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection. 2010

Helen S Atkins, and Stephen Spencer, and Simon D Brew, and Dominic C Jenner, and Armine M Sefton, and Alastair P MacMillan, and Timothy J G Brooks, and Andrew J H Simpson
Department of Biomedical Sciences, Defence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, UK. hsatkins@dstl.gov.uk

The prophylactic potential of the azalide azithromycin as well as the fluoroquinolones trovafloxacin and grepafloxacin was assessed for the control of infection with Brucella melitensis in an experimental mouse model, determined by reduction in splenic bacterial burden. Trovafloxacin showed limited protective efficacy when administered 2h following a low-dose B. melitensis challenge, whereas grepafloxacin was ineffective. In comparison, azithromycin provided significant control of infection both following low- and high-dose challenges. Overall, the data confirm the potential utility of azithromycin in the prophylaxis of brucellosis and suggest that neither trovafloxacin nor grepafloxacin would likely be valuable for post-exposure prophylaxis of Brucella infection.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009287 Naphthyridines A group of two-ring heterocyclic compounds consisting of a NAPHTHALENES double ring in which two carbon atoms, one per each ring, are replaced with nitrogens.
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D002006 Brucellosis Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss. Malta Fever,Undulant Fever,Brucella Infection,Brucellosis, Pulmonary,Cyprus Fever,Gibraltar Fever,Rock Fever,Brucella Infections,Brucelloses,Brucelloses, Pulmonary,Fever, Cyprus,Fever, Gibraltar,Fever, Malta,Fever, Rock,Fever, Undulant,Infection, Brucella,Pulmonary Brucelloses,Pulmonary Brucellosis
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

Helen S Atkins, and Stephen Spencer, and Simon D Brew, and Dominic C Jenner, and Armine M Sefton, and Alastair P MacMillan, and Timothy J G Brooks, and Andrew J H Simpson
Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis for experimental murine melioidosis.
July 2010, International journal of antimicrobial agents,
Helen S Atkins, and Stephen Spencer, and Simon D Brew, and Dominic C Jenner, and Armine M Sefton, and Alastair P MacMillan, and Timothy J G Brooks, and Andrew J H Simpson
Antibacterial activity of azithromycin against Brucella melitensis.
January 1995, Chemotherapy,
Helen S Atkins, and Stephen Spencer, and Simon D Brew, and Dominic C Jenner, and Armine M Sefton, and Alastair P MacMillan, and Timothy J G Brooks, and Andrew J H Simpson
Brucella melitensis invades murine erythrocytes during infection.
September 2014, Infection and immunity,
Helen S Atkins, and Stephen Spencer, and Simon D Brew, and Dominic C Jenner, and Armine M Sefton, and Alastair P MacMillan, and Timothy J G Brooks, and Andrew J H Simpson
[Immunization of ewes against experimental Brucella melitensis infection: comparison of eleven vaccines].
January 1976, Developments in biological standardization,
Helen S Atkins, and Stephen Spencer, and Simon D Brew, and Dominic C Jenner, and Armine M Sefton, and Alastair P MacMillan, and Timothy J G Brooks, and Andrew J H Simpson
Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes.
February 1995, Vaccine,
Helen S Atkins, and Stephen Spencer, and Simon D Brew, and Dominic C Jenner, and Armine M Sefton, and Alastair P MacMillan, and Timothy J G Brooks, and Andrew J H Simpson
Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.
December 2001, Revue scientifique et technique (International Office of Epizootics),
Helen S Atkins, and Stephen Spencer, and Simon D Brew, and Dominic C Jenner, and Armine M Sefton, and Alastair P MacMillan, and Timothy J G Brooks, and Andrew J H Simpson
Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
September 2008, Vaccine,
Helen S Atkins, and Stephen Spencer, and Simon D Brew, and Dominic C Jenner, and Armine M Sefton, and Alastair P MacMillan, and Timothy J G Brooks, and Andrew J H Simpson
[Induced immunity against Brucella; active and passive protection of white rats with formalin-killed bacteria against experimental Brucella melitensis infection].
December 1954, Revista del Instituto de Salubridad y Enfermedades Tropicales,
Helen S Atkins, and Stephen Spencer, and Simon D Brew, and Dominic C Jenner, and Armine M Sefton, and Alastair P MacMillan, and Timothy J G Brooks, and Andrew J H Simpson
In vitro activity of azithromycin and tetracycline against 358 clinical isolates of Brucella melitensis.
March 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Helen S Atkins, and Stephen Spencer, and Simon D Brew, and Dominic C Jenner, and Armine M Sefton, and Alastair P MacMillan, and Timothy J G Brooks, and Andrew J H Simpson
Preparation and Evaluation of Rifampicin and Co-trimoxazole-loaded Nanocarrier against Brucella melitensis Infection
July 2018, Iranian biomedical journal,
Copied contents to your clipboard!